Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

VKTX

Viking Therapeutics Inc

May 29 • 04:00PM ET

32.74

+0.55 1.71 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: MDGL AXSM ACAD KROS KYMR RYTM BMRN NUVL INCY NBIX

| Held by: VTI XBI VB VBK VXF SCHA IWR DFMC VHT IWD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.15	Insider Own	2.80%	Shs Outstand	115.89M	Perf Week	6.71%
Market Cap	3.80B	Forward P/E	-	EPS next Y	-4.75	Insider Trans	-9.98%	Shs Float	112.85M	Perf Month	4.50%
Enterprise Value	3.20B	PEG	-	EPS next Q	-1.23	Inst Own	63.46%	Short Float	19.74%	Perf Quarter	-3.25%
Income	-472.33M	P/S	-	EPS this Y	-48.55%	Inst Trans	0.30%	Short Ratio	9.76	Perf Half Y	-7.67%
Sales	0.00M	P/B	7.56	EPS next Y	-0.30%	ROA	-64.04%	Short Interest	22.28M	Perf YTD	-6.94%
Book/sh	4.33	P/C	6.30	EPS next 5Y	-7.01%	ROE	-70.04%	52W High	43.15 -24.13%	Perf Year	16.26%
Cash/sh	5.19	P/FCF	-	EPS past 3/5Y	-52.71% -42.46%	ROIC	-94.11%	52W Low	22.96 42.60%	Perf 3Y	53.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	3.52% 4.89%	Perf 5Y	524.81%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-259.98%	Oper. Margin	-	ATR (14)	1.41	Perf 10Y	2418.46%
Dividend Ex-Date	-	Quick Ratio	5.72	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	56.51	Recom	1.21
Dividend Gr. 3/5Y	- -	Current Ratio	5.72	EPS Q/Q	-236.44%	SMA20	5.53%	Beta	0.68	Target Price	94.29
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	0.69%	Rel Volume	0.76	Prev Close	32.19
Employees	53	LT Debt/Eq	0.00	Earnings	Apr 29 AMC	SMA200	0.78%	Avg Volume	2.28M	Price	32.74
IPO	Apr 29, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-40.43% -	Trades		Volume	1,744,621	Change	1.71%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)